Free Republic
Browse · Search
General/Chat
Topics · Post Article

Skip to comments.

Therapeutic Management of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Treatment Algorithm; Among all treatment modalities, antimalarial Hydroxychloroquine ranked the highest cure rate
Journal of Pharmaceutical Research International ^ | 09/22/2020 | Zreiq, R., Haouas, N., Khemakhem, A. M., Obeidat, R. M., Ali, R. M., Shammary, A. A. A.-, Alsaif, B.

Posted on 09/27/2020 7:06:33 PM PDT by SeekAndFind

Main Article Content

Rafat Zreiq
Najoua Haouas
Asma M. Khemakhem
Rawan M. Obeidat
Reem M. Ali
Asma Ayyed AL- Shammary
Bandar Alsaif
Fahad D. Algahtani

Abstract

Coronavirus disease 2019 (COVID-19) is emerging contagious pneumonia due to the new Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It initially appeared in Wuhan China in December 2019 then rapidly spread worldwide and became a pandemic. For the time being, there is no specific therapeutic treatment for this disease. Herein, the "state-of-the-art" of treatment modalities was systematically reviewed and ultimately a practical therapeutic algorithm for the COVID-19 management was proposed. The systematic review was performed by using published articles retrieved from Science Direct, MEDLINE, and Scopus databases concerning this topic. Among 1060 articles collected from the different databases, 19 publications were studied in-depth and incorporated in this review. The most three frequently used medications for the treatment of COVID-19 was: the available anti-viral drugs (n= 9), the antimalarial hydroxychloroquine or chloroquine (n = 8), and the passive antibody transfer therapy (n = 2). Among all treatment modalities, antimalarial Hydroxychloroquine ranked the highest cure rate. Therefore, this drug is considered as the first‐line of COVID-19 treatment. The second‐line treatment includes the lopinavir/ritonavir drugs combined with interferon β-1b and ribavirin. Finally, the third‐line treatments include the remdesivir drug and passive antibody transfer therapy. However, our review emphasis the urgent need for adequately designed randomized controlled trials, enabling a more significant comparison between the most used treatment modalities.

Keywords:
COVID-19, therapeutic management, treatment algorithm, Chloroquine, hydroxychloroquine.

CLICK ABOVE ARTICLE LINK FOR THE REST....



TOPICS: Health/Medicine; Science; Society
KEYWORDS: covid19; curerate; hcq; hydroxychloroquine
Navigation: use the links below to view more comments.
first previous 1-2021 last
To: LibFreeUSA

RE: He said: “there’s nothing we can give for this virus”

And this is the issue at hand— Your wife will MOST PROBABLY get well, or simply display NO SYMPTOMS. In a few weeks, when re-tested, she will probably be negative and show antibodies.

The argument against HCQ or Ivermectin has always been this — How do we know that a person got well on his own ( given that 99% of Covid positive people recover ) or because of HCQ, given that your recommendation is to give these drugs EARLY in the disease cycle before hospitalization?


21 posted on 09/30/2020 8:09:46 AM PDT by SeekAndFind
[ Post Reply | Private Reply | To 19 | View Replies]


Navigation: use the links below to view more comments.
first previous 1-2021 last

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
General/Chat
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson